Midas Letter and C-Suite are excited to announce Midas Letter LIVE. Midas Letter highlights the stocks and stories to watch in the Canadian markets today. Host James West is a recognized authority on investing in the emerging company segment having been a regularly featured guest on Business News Network, CNBC, Bloomberg, Reuters, and CTV. James West and guests provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business. Midas Letter is excited to feature all investing content on C-suite.
Khiron Life Sciences (KHRN) President Chris Naprawa on Selling Weed in Mexico
Khiron Life Sciences Corp (CVE:KHRN) (OTCMKTS:KHRNF) President Chris Naprawa is excited about the company extending its distribution agreement with Farmalisto, a leading cosmetics retailer in Latin America, to the Mexican market. The two companies already have a deal to distribute Khiron’s cosmeceutical brand, Kuida, in Colombia and the extension gives Mexico’s population of more than 120 million people access to Khiron’s CBD wellness products. Naprawa explains that CBDs in cosmetics provide hydration and anti-inflammation benefits and Khiron clinics are conducting trials to provide additional research illustrating the efficacy of these products. Naprawa also stresses the importance of medical patients to Khiron’s profitability, indicating that if the company converts one third of its 100,000 patients in Bogota from pharmaceutical treatments to cannabis that switch represents $30 million in annual revenue.